2007
DOI: 10.1007/s12094-007-0051-2
|View full text |Cite
|
Sign up to set email alerts
|

Parotid gland metastasis of a breast cancer

Abstract: Parotid gland metastases from malignant tumors are extremely rare. A 61-year-old woman was diagnosed with an early breast cancer with no expression of oestrogen and progesterone receptors. Five years later the patient presented a tumour in parotid gland. After total parotidectomy, microscopic analysis of the gland demonstrated an invasive duct carcinoma (IDC) with positive expression of oestrogen receptor. The patient was treated with chemotherapy followed by complementary local radiotherapy. Diagnosis of a me… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
9
0
1

Year Published

2008
2008
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(10 citation statements)
references
References 7 publications
(6 reference statements)
0
9
0
1
Order By: Relevance
“…Li et al described that adenocarcinoma, NOS, had an SDC-like area, seen as cribriform epithelioid glands and comedonecrosis, but these areas comprised a small proportion of the tumor cells in the definition of adenocarcinoma, NOS 10 ; therefore, this histological type might not be reliably diagnosed by histology and cytology. Metastasis in the parotid gland has been reported from cutaneous squamous-cell carcinoma, 22 malignant melanoma, 22 Merkel cell carcinoma, 22 rhabdomyosarcoma, 22 renal cell carcinoma, 23 gastric adenocarcinoma, 24 ductal breast carcinoma, 25 and basal cell carcinoma. 26 Such metastatic cancers can be diagnosed cytologically based on clinical findings, with supporting differential diagnosis using immunocytochemistry and the following antibodies: p63 is expressed in squamous-cell carcinoma and in basal cell carcinoma; AR is not expressed in gastric adenocarcinoma or in ductal breast carcinoma; HMB45 is expressed in malignant melanoma; cytokeratin 20 in Merkel cell carcinoma; vimentin in renal cell carcinoma; and desmin in rhabdomyosarcoma.…”
Section: Discussionmentioning
confidence: 99%
“…Li et al described that adenocarcinoma, NOS, had an SDC-like area, seen as cribriform epithelioid glands and comedonecrosis, but these areas comprised a small proportion of the tumor cells in the definition of adenocarcinoma, NOS 10 ; therefore, this histological type might not be reliably diagnosed by histology and cytology. Metastasis in the parotid gland has been reported from cutaneous squamous-cell carcinoma, 22 malignant melanoma, 22 Merkel cell carcinoma, 22 rhabdomyosarcoma, 22 renal cell carcinoma, 23 gastric adenocarcinoma, 24 ductal breast carcinoma, 25 and basal cell carcinoma. 26 Such metastatic cancers can be diagnosed cytologically based on clinical findings, with supporting differential diagnosis using immunocytochemistry and the following antibodies: p63 is expressed in squamous-cell carcinoma and in basal cell carcinoma; AR is not expressed in gastric adenocarcinoma or in ductal breast carcinoma; HMB45 is expressed in malignant melanoma; cytokeratin 20 in Merkel cell carcinoma; vimentin in renal cell carcinoma; and desmin in rhabdomyosarcoma.…”
Section: Discussionmentioning
confidence: 99%
“…We compared findings of hematoxylin-eosin and various immunohistochemical stains, also of the parotid gland after parotidectomy. The comparison showed the immunohistochemical features were very important to make an accurate diagnosis as in our case [7].…”
Section: Discussionmentioning
confidence: 73%
“…Although the optimal therapy sequence is unknown, treatment of PTG metastatic disease is a combination of surgical removal of solitary tumors, chemotherapy, and radiation therapy [2,6,7]. Our patient refused the recommended surgical treatment plan and was treated with a superficial lobe parotidectomy, followed by adjuvant radiotherapy and chemotherapy.…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…Among the histologic subtypes most commonly encountered are renal cell carcinoma 6 , breast cancer 7 , lung cancer 8 , and prostate cancer 9 . Rarely reported entities include adrenal neuroblastoma, rhabdomyosarcoma, leiomyosarcoma, hepatocellular carcinoma, liposarcoma, and urachus adenocarcinoma of the urinary bladder [10][11][12][13] .…”
mentioning
confidence: 99%